Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 358Neoplasms 252Carcinoma, Non-Small-Cell Lung 191Colorectal Neoplasms 174Lung Neoplasms 150Prostatic Neoplasms 148Carcinoma, Hepatocellular 125Leukemia, Myeloid, Acute 94Multiple Myeloma 84Pancreatic Neoplasms 82Neoplasm Metastasis 72Recurrence 67Stomach Neoplasms 66Rectal Neoplasms 65Uterine Cervical Neoplasms 64Ovarian Neoplasms 61Triple Negative Breast Neoplasms 57Squamous Cell Carcinoma of Head and Neck 56Head and Neck Neoplasms 53Glioblastoma 53Brain Neoplasms 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Small Cell Lung Carcinoma 48Endometrial Neoplasms 45Melanoma 43Esophageal Neoplasms 42Colonic Neoplasms 42Disease 41Motor Activity 40Lymphoma 40

Interventions

Pluvicto 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × High-Risk Localized Prostate Cancer × 1 year × Clear all
NCT07550517 2026-04-24

PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Not yet recruiting
60 enrolled
Genitourinary

High-Risk Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡